Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.52 USD | -1.19% | -2.09% | -39.89% |
May. 13 | Ajax Therapeutics, Inc. announced that it has received $95 million in funding from a group of investors | CI |
May. 07 | Ansys Partners With Schrodinger to Accelerate Materials Development | MT |
Financials (USD)
Sales 2024 * | 205M | Sales 2025 * | 278M | Capitalization | 1.56B |
---|---|---|---|---|---|
Net income 2024 * | -199M | Net income 2025 * | -198M | EV / Sales 2024 * | 5.93 x |
Net cash position 2024 * | 349M | Net cash position 2025 * | 317M | EV / Sales 2025 * | 4.48 x |
P/E ratio 2024 * |
-7.9
x | P/E ratio 2025 * |
-8.13
x | Employees | 867 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.31% |
Latest transcript on Schrödinger, Inc.
1 day | -1.19% | ||
1 week | -2.09% | ||
1 month | -14.81% | ||
3 months | -19.73% | ||
6 months | -33.76% | ||
Current year | -39.89% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Taffy
FOU | Founder | - | 20-12-31 |
Ramy Farid
CEO | Chief Executive Officer | 59 | 01-12-31 |
Geoffrey Porges
DFI | Director of Finance/CFO | 63 | 22-08-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arun Oberoi
BRD | Director/Board Member | 70 | 22-05-16 |
Michael Lynton
CHM | Chairman | 64 | 17-12-31 |
Gary Ginsberg
BRD | Director/Board Member | 61 | 20-04-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.98% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 21.52 | -1.19% | 589,252 |
24-05-30 | 21.78 | +1.73% | 671,574 |
24-05-29 | 21.41 | -3.17% | 499,039 |
24-05-28 | 22.11 | +0.59% | 524,869 |
24-05-24 | 21.98 | +0.73% | 445,447 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.89% | 1.56B | |
+8.91% | 85.92B | |
+5.14% | 77.91B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B | |
-26.47% | 21.52B |
- Stock Market
- Equities
- SDGR Stock